Additionally, Economopoulou et al. investigated the significance of IDO1 mRNA levels in circulating tumour cells at baseline and after chemotherapy in HNSCC patients and found that IDO1 was significantly overexpressed at baseline compared with post-treatment (Economopoulou et al. 2020). This evidence concerns the gene IDO1 and neoplasm.